How is amyloidosis related to myeloma?

If you are MRD positive, should you continue to have MRD testing completed?
Is there a certain type of myeloma patient who would be more likely to develop amyloidosis?
Why is MRD testing important for patients to get done?
What are some promising investigational agents and novel therapies for relapsed/refractory patients?
Who should consider MRD testing and when should it be done?
Are there any targeted approaches for specific genetic subsets that patients should ask about?